Company Overview
Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022), is an innovation focused global discovery, development and manufacturing organization providing integrated scientific services to pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical industries around the world. Syngene’s clientele include world leaders such as Bristol-Myers Squibb, Baxter, Amgen, GSK, Merck KGaA and Herbalife. Syngene’s innovative culture is driven by the passion of its 3500 strong team of scientists who work with clients from around the world to solve their scientific problems, improve R&D productivity, accelerate time to market and lower innovation costs. For more details, visit www.syngeneintl.com